// App-Quantinova.ai

SAT0172 : UTILIZATION OF HYDROXYCHLOROQUINE AND CORTICOSTEROIDS AMONG LUPUS PATIENTS WITH INCIDENT END-STAGE RENAL DISEASE (ESRD) ONSET: A LONGITUDINAL STUDY USING USRDS REGISTRY

Researchers

Presenter

  • A. R. Broder

Principal Investigators

  • W. Mowrey

  • A. Valle

  • B. Goilav

  • K. Yoshida

  • K. Costenbader

Medical Centers

  • Montefiore/Einstein, Medicine/Rheumatology, Bronx, United States of America

  • Montefiore, Bronx, United States of America

  • Montefiore, Bronx, United States of America

  • Montefiore, Bronx, United States of America

  • Evidera, Seattle, United States of America

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Microvascular complications of diabetes 1

  • Lupus

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Merck & Co.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved